Mirum Pharmaceuticals logo

Virtual Rare Disease Specialist (Contract)

Mirum Pharmaceuticals

Any City, USRemotePosted 1 day ago
ContractEntry LevelCommercial & Pharma SalesPharmaceutical
Original posting ↗

Summary

The Virtual Rare Disease Specialist Contract (VRDS) supports Mirum's bile acid portfolio, including CHOLBAM and CTEXLI, and is responsible for expanding healthcare professional (HCP) engagement, generating and nurturing qualified leads, and supporting patient identification opportunities. Working as an extension of the field sales organization, the VRDS conducts approximately 80% of work virtually and travels within the United States approximately 20% of the time.

Job description

Position Summary

The Virtual Rare Disease Specialist Contract (VRDS) supports Mirum's bile acid portfolio, including CHOLBAM and CTEXLI, and is responsible for expanding healthcare professional (HCP) engagement, generating and nurturing qualified leads, and supporting patient identification opportunities. Working as an extension of the field sales organization, the VRDS conducts approximately 80% of work virtually and travels within the United States approximately 20% of the time.

Job Functions/Responsibilities

  • Proactively identifies and engages HCPs treating patients with Smith-Lemli-Opitz syndrome (SLOS), Zellweger spectrum disorders (ZSD), and cerebrotendinous xanthomatosis (CTX).
  • Generates and qualifies new HCP leads through targeted outreach, disease awareness, and approved promotional activities.
  • Nurtures RAM-identified CHOLBAM leads through consistent follow-up, relationship development, and educational engagement.
  • Executes follow-up with HCPs identified through CTEXLI nonpersonal promotion (NPP) campaigns and other marketing initiatives.
  • Provides in-person coverage at designated medical conferences, including HCP engagement, lead generation, and post-conference follow-up.
  • Collaborates closely with RAMs to prioritize opportunities, coordinate customer outreach, and facilitate timely lead handoffs.
  • Develops and executes strategic virtual engagement plans to maximize HCP reach and account penetration within assigned regions.
  • Effectively communicates complex scientific information and approved product messaging to HCPs.
  • Maintains accurate and timely documentation of HCP interactions, lead status, and follow-up activities within the designated CRM system.
  • Demonstrates accountability for established lead generation, HCP engagement, and lead progression objectives.
  • Collaborates cross-functionally with internal stakeholders, including Sales, Marketing, Medical, Market Access, and Compliance.
  • Maintains high standards of integrity and adherence to all applicable laws, regulations, and company compliance policies.

Qualifications

  • Bachelor's degree or relevant experience, skills, and demonstrated ability to succeed in the role will be considered.
  • Entry-level and early-career candidates encouraged to apply; prior pharmaceutical or biotechnology experience is not required.
  • Demonstrated ambition, initiative, and a strong desire to build a career in sales.
  • Highly motivated, results-oriented self-starter with a competitive mindset and willingness to take ownership of performance goals.
  • Strong interpersonal and communication skills, with the confidence to initiate conversations, build relationships, and engage healthcare professionals.
  • Resilient and persistent, with the ability to navigate rejection, overcome objections, and consistently pursue opportunities.
  • Highly coachable, intellectually curious, and eager to learn complex clinical information and develop selling skills.
  • Strong organizational skills with the ability to independently manage outreach, follow-up, and competing priorities.
  • Comfortable leveraging technology, CRM platforms, and digital communication tools to drive engagement.
  • Prior experience in sales, customer service, business development, or other relationship-driven roles is a plus, but not required.
  • Willingness and ability to travel domestically approximately 20% of the time.

Performance Expectations

The VRDS will be accountable for achieving established objectives related to lead generation, lead nurturing, HCP engagement, and field collaboration. The $15,000 performance bonus is contingent on achievement of separately documented performance criteria, measurement period, and payment terms; it is not guaranteed.

Requirements

  • Bachelor's degree or relevant experience, skills, and demonstrated ability to succeed in the role will be considered
  • Entry-level and early-career candidates encouraged to apply; prior pharmaceutical or biotechnology experience is not required
  • Demonstrated ambition, initiative, and a strong desire to build a career in sales
  • Highly motivated, results-oriented self-starter with a competitive mindset and willingness to take ownership of performance goals
  • Strong interpersonal and communication skills, with the confidence to initiate conversations, build relationships, and engage healthcare professionals
  • Resilient and persistent, with the ability to navigate rejection, overcome objections, and consistently pursue opportunities
  • Highly coachable, intellectually curious, and eager to learn complex clinical information and develop selling skills
  • Strong organizational skills with the ability to independently manage outreach, follow-up, and competing priorities
  • Comfortable leveraging technology, CRM platforms, and digital communication tools to drive engagement
  • Willingness and ability to travel domestically approximately 20% of the time

Benefits

  • Performance Bonus

Company overview

Mirum Pharmaceuticals is a biopharmaceutical company dedicated to developing and commercializing transformative therapies for rare liver diseases. Founded in 2018 and headquartered in Foster City, California, the company focuses on addressing critical unmet medical needs in patients with cholestatic liver conditions. Mirum has three approved medications: LIVMARLI® (maralixibat), an IBAT inhibitor approved for cholestatic pruritus in Alagille syndrome and progressive familial intrahepatic cholestasis; CHOLBAM® (cholic acid) capsules for bile acid synthesis disorders; and CTEXLI™ (chenodiol) tablets for cerebrotendinous xanthomatosis. The company's late-stage pipeline includes volixibat for primary sclerosing cholangitis and primary biliary cholangitis, and MRM-3379 for Fragile X syndrome. Mirum operates globally with commercial access in over 30 countries and has demonstrated strong revenue growth, with 2024 net product sales reaching $336.4 million. The company is publicly traded on NASDAQ under the ticker MIRM and employs approximately 201-500 people.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.